Novartis and Boston Scientific Slide, Intel Price Hikes | Stock Movers

Novartis shares declined after a late-stage clinical trial for a treatment of a rare muscle-wasting disease failed. Boston Scientific shares moved lower following disclosure that a cybersecurity incident has affected its product shipments and will cause the company to miss its 2026 sales growth and earnings estimates. Intel shares rose on a Bloomberg report that the company could increase computer chip prices in the coming month.

Next story